Humira Buyers Get Backing Against AbbVie's 'Patent Thicket'
Consumer advocates, academics and a drug store industry group all have urged the Seventh Circuit to revive a lawsuit claiming AbbVie built an anti-competitive "patent thicket" around its blockbuster immunosuppressant Humira...To view the full article, register now.
Already a subscriber? Click here to view full article